WHO: New research on postpartum haemorrhage in Lancet

6 MARCH 2012 | LONDON-GENEVA - Findings on the prevention of postpartum haemorrhage (PPH) have important implications for expanding access to effective care and could have a substantial impact on maternal survival in places where access to skilled medical staff is difficult.

Between 2009 and 2010, the Programme of Research, Development and Research Training in Human Reproduction (HRP) coordinated a randomized controlled trial in eight countries that studied a simplified approach to management of the third stage of labour without controlled cord traction. More than 24 000 women participated in the study. It showed that omitting controlled cord traction has little effect on the risk of severe bleeding and indicates that effective prevention of PPH could be accomplished with just a uterotonic agent --primarily oxytocin.

The findings have important implications for expanding access to effective care and could have a substantial impact on maternal survival in places where access to skilled medical staff is difficult. The study was written up and published in the 6 March 2012 edition of The Lancet.

Share